121.
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
by Baskin, Jacquelyn L, MD
The Lancet (British edition), 2009, Vol.374 (9684), p.159-169
122.
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
by Timpson, Nicholas J
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1954-1959
123.
Systems biology and cardiac arrhythmias
by Grace, Andrew A, Dr
The Lancet (British edition), 2012, Vol.380 (9852), p.1498-1508
124.
Essential hypertension
by Staessen, Jan A
The Lancet (British edition), 2003-05-10, Vol.361 (9369), p.1629-1641
125.
The fetal insulin hypothesis : an alternative explanation of the association of low birthweight with diabetes and vascular disease
by HATTERSLEY, A. T
The Lancet (British edition), 1999, Vol.353 (9166), p.1789-1792
126.
Dyslipidaemia
by Durrington, Paul
The Lancet (British edition), 2003, Vol.362 (9385), p.717-731
127.
Pathogenesis and genetics of pre-eclampsia
by Roberts, JM
The Lancet (British edition), 2001, Vol.357 (9249), p.53-56
128.
Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight
by VAESSEN, Norbert
The Lancet (British edition), 2002, Vol.359 (9311), p.1036-1037
129.
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
by Humphries, Steve E
The Lancet (British edition), 2001, Vol.358 (9276), p.115-119
130.
Telomere shortening in atherosclerosis
by Samani, Nilesh J
The Lancet (British edition), 2001-08-11, Vol.358 (9280), p.472-473
131.
Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies
by Wheeler, Jeremy G
The Lancet (British edition), 2004, Vol.363 (9410), p.689-695
132.
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study
by Traboulsee, Anthony L, Dr
The Lancet (British edition), 2014, Vol.383 (9912), p.138-145
133.
Addressing the complexity of cardiovascular disease by design
by Lotta, Luca A
The Lancet (British edition), 2011, Vol.377 (9763), p.356-358
134.
Implantable cardioverter defibrillators and cardiac resynchronisation therapy
by Holzmeister, Johannes, Dr
The Lancet (British edition), 2011, Vol.378 (9792), p.722-730
135.
Hypoplastic left heart syndrome
by Barron, David J, FRCS
The Lancet (British edition), 2009, Vol.374 (9689), p.551-564
136.
Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia
by Wiegman, Albert
The Lancet (British edition), 2004-01-31, Vol.363 (9406), p.369-370
137.
Statin treatment: can genetics sharpen the focus?
by Schunkert, Heribert
The Lancet (British edition), 2015, Vol.385 (9984), p.2227-2229
138.
Response to antiplatelet treatment: from genes to outcome
by Giusti, Betti
The Lancet (British edition), 2010, Vol.376 (9749), p.1278-1281
139.
Polygenic familial hypercholesterolaemia: does it matter?
by Stein, Evan A
The Lancet (British edition), 2013, Vol.381 (9874), p.1255-1257
140.
Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction
by Tiret, L
The Lancet (British edition), 1994-10-01, Vol.344 (8927), p.910-913
